Rachel Female (F) Gibbs

Dr. Rachel Female (F) Gibbs

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Translational Animal Science
Verified
Journal Article
Open access
PDF file
RGRachel Female (F) Gibbs
Rachel Female (F) Gibbs
RSRebecca M Swanson
Rebecca M Swanson
JBJoslyn K Beard
Joslyn K Beard
TSTy B Schmidt
Ty B Schmidt
JPJessica Lynn Petersen
Jessica Lynn Petersen
DYDustin T Yates
Dustin T Yates
Low birthweight in livestock results from stress-induced intrauterine growth restriction (IUGR; Yates et al., 2018). IUGR fetuses exhibit diminished muscle growth that persists in the neonatal stage, leading to asymmetric body composition and decreased weight gain ( Cadaret et al., 2019). Ultimately, low birthweight diminishes yield and carcass merit at harvest ( Greenwood et al., 2000), making effective postnatal treatment strategies to improve IUGR growth outcomes necessary. In this study, we examined the benefits of injecting the β2 agonist clenbuterol daily to target adrenergic adaptations that we previously observed in IUGR muscle ( Posont et al., 2018; Yates et al., 2018). We hypothesized that IUGR-induced growth deficits would persist at the juvenile stage, manifesting in inferior body composition and carcass traits. We also postulated that clenbuterol would at least partially recover growth and body symmetry. Our objective was to test this hypothesis by assessing growth metrics and body composition in IUGR-born lambs hand-reared to 60 d of age and supplemented daily with injectable clenbuterol.

6 September 2023 in Frontiers in Physiology
Verified
Journal Article
Open access
RGRachel Female (F) Gibbs
Rachel Female (F) Gibbs
RSRebecca M. Swanson
Rebecca M. Swanson
JBJoslyn K. Beard
Joslyn K. Beard
ZHZena M. Hicks
Zena M. Hicks
MMMicah S. Most
Micah S. Most
DYDustin T Yates
Dustin T Yates
Background: Intrauterine growth restriction (IUGR) is associated with reduced β2 adrenergic sensitivity, which contributes to poor postnatal muscle growth. The objective of this study was to determine if stimulating β2 adrenergic activity postnatal would rescue deficits in muscle growth, body composition, and indicators of metabolic homeostasis in IUGR offspring.Methods: Time-mated ewes were housed at 40°C from day 40 to 95 of gestation to produce IUGR lambs. From birth, IUGR lambs received daily IM injections of 0.8 μg/kg clenbuterol HCl (IUGR+CLEN; n = 11) or saline placebo (IUGR; n = 12). Placebo-injected controls (n = 13) were born to pair-fed thermoneutral ewes. Biometrics were assessed weekly and body composition was estimated by ultrasound and bioelectrical impedance analysis (BIA). Lambs were necropsied at 60 days of age.Results: Bodyweights were lighter (p ≤ 0.05) for IUGR and IUGR+CLEN lambs than for controls at birth, day 30, and day 60. Average daily gain was less (p ≤ 0.05) for IUGR lambs than controls and was intermediate for IUGR+CLEN lambs. At day 58, BIA-estimated whole-body fat-free mass and ultrasound-estimated loin eye area were less (p ≤ 0.05) for IUGR but not IUGR+CLEN lambs than for controls. At necropsy, loin eye area and flexor digitorum superficialis muscles were smaller (p ≤ 0.05) for IUGR but not IUGR+CLEN lambs than for controls. Longissimus dorsi protein content was less (p ≤ 0.05) and fat-to-protein ratio was greater (p ≤ 0.05) for IUGR but not IUGR+CLEN lambs than for controls. Semitendinosus from IUGR lambs had less (p ≤ 0.05) β2 adrenoreceptor content, fewer (p ≤ 0.05) proliferating myoblasts, tended to have fewer (p = 0.08) differentiated myoblasts, and had smaller (p ≤ 0.05) muscle fibers than controls. Proliferating myoblasts and fiber size were recovered (p ≤ 0.05) in IUGR+CLEN lambs compared to IUGR lambs, but β2 adrenoreceptor content and differentiated myoblasts were not recovered. Semitendinosus lipid droplets were smaller (p ≤ 0.05) in size for IUGR lambs than for controls and were further reduced (p ≤ 0.05) in size for IUGR+CLEN lambs.Conclusion: These findings show that clenbuterol improved IUGR deficits in muscle growth and some metabolic parameters even without recovering the deficit in β2 adrenoreceptor content. We conclude that IUGR muscle remained responsive to β2 adrenergic stimulation postnatal, which may be a strategic target for improving muscle growth and body composition in IUGR-born offspring.

22 May 2025 in Metabolites
Verified
Journal Article
Open access
PDF file
MWMelanie White
Melanie White
RGRachel Female (F) Gibbs
Rachel Female (F) Gibbs
PGPablo C. Grijalva
Pablo C. Grijalva
ZHZena M. Hicks
Zena M. Hicks
HBHaley N. Beer
Haley N. Beer
DYDustin T Yates
Dustin T Yates
Background/Objectives: Intrauterine growth restriction (IUGR) is associated with enhanced inflammatory activity, poor skeletal muscle glucose metabolism, and pancreatic β cell dysfunction that persist in offspring. We hypothesized that targeting heightened inflammation in IUGR-born neonatal lambs by supplementing anti-inflammatory ω-3 polyunsaturated fatty acids (ω-3 PUFAs) would improve metabolic outcomes. Methods: Maternal heat stress was used to produce IUGR lambs, which received daily oral boluses of ω-3 PUFA Ca2+ salts or placebo for 30 days. Results: Greater circulating TNFα and semitendinosus IL6R in IUGR lambs were fully resolved by ω-3 PUFA, and impaired glucose-stimulated insulin secretion, muscle glucose oxidation, and hypertension were partially rescued. Impaired glucose oxidation by IUGR muscle coincided with a greater glycogen content that was completely reversed by ω-3 PUFA and greater lactate production that was partially reversed. Ex vivo O2 consumption was increased in IUGR muscle, indicating compensatory lipid oxidation. This too was alleviated by ω-3 PUFA. Conversely, ω-3 PUFA had little effect on IUGR-induced changes in lipid flux and hematology parameters, did not resolve greater muscle TNFR1, and further reduced muscle β2-adrenoceptor content. Conclusions: These findings show that targeting elevated inflammatory activity in IUGR-born lambs in the early neonatal period improved metabolic outcomes, particularly muscle glucose metabolism and β cell function.

6 November 2023 in Journal of Animal Science
Verified
Journal Article
Open access
PDF file
PGPablo Cesar C Grijalva
Pablo Cesar C Grijalva
MMMicah S Most
Micah S Most
HBHaley N Beer
Haley N Beer
RGRachel Female (F) Gibbs
Rachel Female (F) Gibbs
ZHZena M Hicks
Zena M Hicks
DYDustin T Yates
Dustin T Yates
Heat stress is costly for livestock production due to its impact on metabolism, which negatively affects health and growth. Previous pair-fed studies demonstrated that heat stress-induced inflammation is associated with disruptions in metabolism and growth. Therefore, the objective of this study was to determine whether targeting systemic inflammation in heat-stressed wethers improves metabolic and stress indicators. Feedlot wethers were randomly assigned to 30-d heat stress (40°C; THI = 85) or were pair-fed under thermoneutral conditions (controls; 25°C; n = 11). Heat-stressed wethers were administered oral fish oil capsules twice daily (HeatStress+FO; 2,400 mg/d; n = 11), injected with dexamethasone every 3 d (HeatStress+DEX; 0.15 mg/kg, i.m.; n = 11), or received no intervention (HeatStress; n = 11). Plasma hormones and lipids were assessed over the 30-d period, and soleus muscle and adipose tissue were collected at necropsy for ex vivo glucose metabolism studies and non-esterified fatty acid (NEFA) mobilization analyses, respectively. Plasma TNFα was up to 3-fold greater (P < 0.05) in HeatStress wethers than controls throughout the study. By the end of the study, plasma TNFα in HeatStress+DEX and HeatStress+FO was reduced (P < 0.05) by 38% and 47%, respectively, compared with HeatStress and did not differ from controls. Plasma insulin did not differ among groups early in the study but by d 30 were increased (P < 0.05) in HeatStress and HeatStress+DEX compared with controls and HeatStress+FO. Blood glucose-to-insulin ratios were less (P < 0.05) for HeatStress wethers than controls throughout the study and were intermediate for HeatStress+DEX and HeatStress+FO. Plasma cortisol did not differ among groups and was less (P < 0.05) at d 30 than d -3 for all weathers. Plasma eicosapentaenoic acid and triglycerides were 15% to 22% less (P < 0.05) for HeatStress and HeatStress+DEX but not HeatStress+FO than for controls throughout the study. High density lipoprotein-bound cholesterol was 8% and 22% less (P < 0.05), respectively, for HeatStress and HeatStress+DEX wethers but not HeatStress+FO wethers compared with controls. Ex vivo basal and insulin-stimulated glucose oxidation rates were reduced (P < 0.05) by 32% in muscle from HeatStress wethers but not HeatStress+DEX, or HeatStress+FO wethers compared with muscle from controls. Glucose uptake rates did not differ among groups. Mobilization of NEFA was reduced (P < 0.05) by 19% and 37%, respectively, in fat from HeatStress wethers and HeatStress+DEX wethers compared with controls and was intermediate in fat from HeatStress+FO wethers. These data indicate that supplementation of DEX and FO partially improve muscle-specific glucose metabolism as well as lipid homeostasis and stress indicators, which provides a fundamental basis for heat stress interventions that utilize anti-inflammatory supplements.

6 November 2023 in Journal of Animal Science
Verified
Journal Article
Open access
PDF file
MWMelanie R White
Melanie R White
RGRachel Female (F) Gibbs
Rachel Female (F) Gibbs
PGPablo Cesar C Grijalva
Pablo Cesar C Grijalva
ZHZena M Hicks
Zena M Hicks
HBHaley N Beer
Haley N Beer
DYDustin T Yates
Dustin T Yates
Maternofetal heat stress during placental development induces fetal intrauterine growth restriction (IUGR), which in turn reduces birthweight. IUGR-born livestock exhibit deficits in insulin stimulus-secretion coupling and glucose metabolism that contribute to poor growth efficiency. Thus, our objective was to determine whether daily oral supplementation of Ca2+ salts of ω-3 polyunsaturated fatty acids (ω-3 PUFA) to IUGR-born neonatal lambs improves glucose-stimulated insulin secretion and other indicators of metabolic efficiency. Maternal heat stress (40°C, 35% humidity, THI = 85) from d 40 to 95 of gestation was used to induce IUGR. Lambs were weaned at birth and hand-reared on milk replacer. Beginning at birth, lambs received daily oral boluses of 0.5 mL molasses containing 0 or 0.42 g/kg bodyweight of ω-3 PUFA (Virtus Nutrition). All lambs were fitted with femoral catheters at d 24 and a square-wave hyperglycemic clamp study was performed on d 28 to assess basal (i.e., resting) and glucose-stimulated insulin secretion (GSIS). Blood glucose concentrations did not differ among IUGR lambs (n = 8), IUGR+ω-3 lambs (n = 7), and controls (n = 12), but by study design were increased (P < 0.05) 205% from basal during hyperglycemic periods. Basal plasma insulin concentrations did not differ among groups, but basal glucose-to-insulin ratios were greater (P < 0.05) for IUGR+ω-3 lambs than for controls or IUGR lambs. During hyperglycemia, plasma insulin concentrations were 53% less (P < 0.05) for IUGR lambs but only 30% less (P < 0.05) for IUGR+ω-3 lambs compared with controls. Hyperglycemic glucose-to-insulin ratios were greater (P < 0.05) for IUGR lambs (3.24 ± 0.59) compared with controls (1.10 ± 0.29) and were intermediate for IUGR+ω-3 lambs (2.08 ± 0.86). Blood lactate concentrations did not differ among groups or between periods, but blood pH was was greater (P < 0.05) for IUGR (7.448 ± 0.006) and IUGR+ω-3 lambs (7.439 ± 0.003) compared with controls (7.422 ± 0.004). Blood partial pressure of CO2 was less (P < 0.05) for IUGR lambs (43.0 ± 0.3 mmHg) than for controls (46.7 ± 0.9 mmHg) and was intermediate for IUGR+ω-3 lambs (44.0 ± 0.4 mmHg). Blood HCO3 concentrations and O2-bound hemoglobin were greater (P < 0.05) for IUGR and IUGR+ω-3 lambs than for controls. Blood Na+ tended to be less (P = 0.07) and blood K+ was less (P < 0.05) for IUGR and IUGR+ω-3 lambs than for controls. Blood Ca2+ was less (P < 0.05) for IUGR lambs but not for IUGR+ω-3 lambs than for controls. These findings demonstrate that daily oral supplementation of Ca2+ salts of ω-3 PUFA improved deficits in insulin stimulus-secretion coupling and several other metabolic indicators observed in IUGR-born offspring. However, it did not improve all electrolyte concentrations or acid-base balance of the blood.

6 November 2023 in Journal of Animal Science
Verified
Journal Article
Open access
PDF file
MWMelanie R White
Melanie R White
RGRachel Female (F) Gibbs
Rachel Female (F) Gibbs
PGPablo Cesar C Grijalva
Pablo Cesar C Grijalva
ZHZena M Hicks
Zena M Hicks
HBHaley N Beer
Haley N Beer
DYDustin T Yates
Dustin T Yates
Low birthweight due to fetal intrauterine growth restriction (IUGR) often results from maternofetal heat stress. IUGR fetuses exhibit enhanced inflammatory tone, which persists after birth and impacts body composition, skeletal muscle growth, and metabolic function. Therefore, our objective was to determine whether daily oral supplementation of Ca2+ salts of ω-3 polyunsaturated fatty acids (ω-3 PUFA) to IUGR-born neonatal lambs improved inflammatory tone, body composition, and growth metrics. Pregnant ewes were exposed to heat stress (40°C, 35% humidity, THI = 85) from d 40 to 95 of gestation to induce IUGR. Lambs were weaned at birth and hand-reared on milk replacer. Daily oral boluses of 0.5 mL molasses containing 0 or 0.42 g/kg bodyweight of ω-3 PUFA (Virtus Nutrition) were administered. Femoral catheters were placed at d 24 and lambs were necropsied at d 30. At birth, IUGR lambs (n = 8; 3.12 ± 0.34 kg) and IUGR+ω-3 lambs (n = 7; 3.67 ± 0.32 kg) were lighter (P < 0.05) than controls (n = 12; 4.28 ± 0.15 kg). Plasma TNFα concentrations were greater (P < 0.05) at birth for IUGR (557 ± 121 pg/mL) and IUGR+ω-3 lambs (437 ± 82 pg/mL) than for controls (213 ± 78 pg/mL). Plasma TNFα concentrations remained increased (P < 0.05) for IUGR lambs but not for IUGR+ω-3 compared with controls at 2, 3, and 4 wk of age. Adjusted 30-d bodyweights were lighter (P < 0.05) for IUGR lambs (9.83 ± 0.6 kg) but not for IUGR+ω-3 lambs (11.59 ± 0.4 kg) than for controls (12.35 ± 0.2 kg). Heart and brain weights were 17% and 6% lighter (P < 0.05), respectively, for IUGR lambs than for controls. Brain weight deficits were resolved in IUGR+ω3 lambs, but heart weights did not differ between IUGR and IUGR+ω-3 IUGR lambs. Crown circumference/ bodyweight, abdominal circumference/ bodyweight, and cannon bone length/ bodyweight (indicators of asymmetric body composition) were 11% to 15% greater (P < 0.05) for IUGR lambs than for IUGR+ω-3 lambs or controls. At necropsy, IUGR lambs had lighter (P < 0.05) whole hindlimbs (29%) and flexor digitorum superficialis (24%), soleus (36%), biceps femoris (25%), semitendinosus (24%), gastrocnemius (29%), and longissimus dorsi (26%) muscles compared with controls. Weight deficits were partially or fully resolved in IUGR+ω-3 lambs for whole hindlimbs and for all muscles but the soleus, which did not differ from IUGR lambs. These findings demonstrate that daily oral supplementation of Ca2+ salts of ω-3 PUFA reduced the enhanced inflammatory tone observed in IUGR-born offspring, which coincided with improved skeletal muscle growth and indicators of symmetrical body composition.